BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21049561)

  • 1. Staging systems for predicting survival of patients with hepatocellular carcinoma after surgery.
    Xu LB; Wang J; Liu C; Pang HW; Chen YJ; Ou QJ; Chen JS
    World J Gastroenterol; 2010 Nov; 16(41):5257-62. PubMed ID: 21049561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPI.
    Lu W; Dong J; Huang Z; Guo D; Liu Y; Shi S
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1874-8. PubMed ID: 18752560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the Predictive Values of Eight Staging Systems for Primary Liver Cancer in Prognosis of Combined Hepatocellular-cholangiocellular Carcinoma Patients after Surgery].
    Li H; Wang XT; Zhang AQ; Meng XF; Yu Q; Lü WP; Duan WD; Dong JH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Apr; 38(2):175-81. PubMed ID: 27181894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival Predictability Between the American Joint Committee on Cancer 8th Edition Staging System and the Barcelona Clinic Liver Cancer Classification in Patients with Hepatocellular Carcinoma.
    Chen LJ; Chang YJ; Chang YJ
    Oncologist; 2021 Mar; 26(3):e445-e453. PubMed ID: 32969134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy.
    Chen TW; Chu CM; Yu JC; Chen CJ; Chan DC; Liu YC; Hsieh CB
    Eur J Surg Oncol; 2007 May; 33(4):480-7. PubMed ID: 17129701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis evaluation in patients with hepatocellular carcinoma after hepatectomy: comparison of BCLC, TNM and Hangzhou criteria staging systems.
    Liu C; Duan LG; Lu WS; Yan LN; Xiao GQ; Jiang L; Yang J; Yang JY
    PLoS One; 2014; 9(8):e103228. PubMed ID: 25133493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma in multiethnic Asians: Real-world perspective.
    Li JW; Goh BG; Chang PE; Tan CK
    World J Gastroenterol; 2017 Jun; 23(22):4054-4063. PubMed ID: 28652658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?
    Kim KM; Sinn DH; Jung SH; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Liver Int; 2016 Oct; 36(10):1490-7. PubMed ID: 26936471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of different clinical staging systems for hepatocellular carcinoma].
    Qu Q; Rui JA; Wang SB; Chen SG; Zhou L; Han K; Wei X; Zhang N; Zhao HT; Cheng EC
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):155-8. PubMed ID: 16750027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the seventh edition of the American Joint Committee on Cancer tumour-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system.
    Chan AC; Fan ST; Poon RT; Cheung TT; Chok KS; Chan SC; Lo CM
    HPB (Oxford); 2013 Jun; 15(6):439-48. PubMed ID: 23659567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluations of seven different clinical staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection].
    Zhao J; Yan T; Huang Z; Bi X; Zhao H; Zhou J; Li Z; Li Y; Li C; Cai J
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(12):903-7. PubMed ID: 24854909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatectomy for ruptured hepatocellular carcinoma classified as Barcelona Clinic Liver Cancer stage 0/A: The optimal treatment.
    Xia F; Huang Z; Zhang Q; Ndhlovu E; Zhang M; Chen X; Chen Y; Zhang B; Zhu P
    Eur J Surg Oncol; 2022 Sep; 48(9):2014-2022. PubMed ID: 35595579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can More Aggressive Treatment Improve Prognosis in Patients with Hepatocellular Carcinoma? A Direct Comparison of the Hong Kong Liver Cancer and Barcelona Clinic Liver Cancer Algorithms.
    Lee YS; Seo YS; Kim JH; Lee J; Kim HR; Yoo YJ; Kim TS; Kang SH; Suh SJ; Joo MK; Jung YK; Lee BJ; Yim HJ; Yeon JE; Kim JS; Park JJ; Um SH; Bak YT; Byun KS
    Gut Liver; 2018 Jan; 12(1):94-101. PubMed ID: 28873509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.
    Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Chau GY; Lui WY; Lee SD; Wu JC
    J Gastroenterol Hepatol; 2005 May; 20(5):765-71. PubMed ID: 15853992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proposed modification for the Barcelona Clinic Liver Cancer staging system: Adding bile duct tumor thrombus status in patients with hepatocellular carcinoma.
    Lu WP; Tang HW; Yang ZY; Jiang K; Chen YL; Lu SC
    Am J Surg; 2020 Oct; 220(4):965-971. PubMed ID: 32336518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of unresectable hepatocellular carcinoma: comparison of seven staging systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese cohort.
    Zhang JF; Shu ZJ; Xie CY; Li Q; Jin XH; Gu W; Jiang FJ; Ling CQ
    PLoS One; 2014; 9(3):e88182. PubMed ID: 24609114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognosis and survival analysis according to seven staging systems of hepatocellular carcinoma following curative resection.
    Choi SB; Lee JG; Kim KS; Yoon DS; Choi JS; Lee WJ; Kim BR
    Hepatogastroenterology; 2008; 55(88):2140-5. PubMed ID: 19260493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection criteria for hepatic resection in intermediate-stage (BCLC stage B) multiple hepatocellular carcinoma.
    Wada H; Eguchi H; Noda T; Ogawa H; Yamada D; Tomimaru Y; Tomokuni A; Asaoka T; Kawamoto K; Gotoh K; Marubashi S; Umeshita K; Nagano H; Doki Y; Mori M
    Surgery; 2016 Nov; 160(5):1227-1235. PubMed ID: 27395761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.